• Dissecting Drug-Induced Effects: In Vitro Tools in Cancer Re

  2026-05-14

  Schwartz’s dissertation advances in vitro evaluation of anticancer drugs by distinguishing between proliferative arrest and cell death, two mechanistically distinct responses that are often conflated in standard assays. These refined methods improve the interpretation of drug efficacy, enabling more precise comparisons and better-informed preclinical decisions.

• Applied Workflows with EZ Cap Cy5 Firefly Luciferase mRNA

  2026-05-13

  EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) unlocks dual-modality imaging and real-time mRNA tracking for advanced gene delivery studies. Its Cap1 capping, 5-moUTP modification, and Cy5 labeling offer unmatched workflow flexibility, stability, and sensitivity—outperforming conventional constructs for both mechanistic research and translational optimization.

• Meropenem Trihydrate: Carbapenem Antibiotic Workflows & Tips

  2026-05-13

  Meropenem trihydrate empowers researchers with robust, reproducible protocols for resistance phenotyping and infection modeling. This guide translates recent metabolomics breakthroughs and troubleshooting strategies into actionable workflows, ensuring optimal use of APExBIO’s gold-standard carbapenem antibiotic.

• Genotyping Kit for Target Alleles: Transforming Precision in

  2026-05-12

  Explore how the Genotyping Kit for target alleles of insects, tissues, fishes and cells streamlines DNA preparation and empowers advanced genetic analysis. This in-depth review reveals novel scientific insights and practical benefits for molecular biology genotyping research.

• Danazol (Danocrine) in Endocrine Research: Applied Workflows

  2026-05-12

  Leverage high-purity Danazol from APExBIO to model steroidogenesis inhibition, LH suppression, and androgen receptor signaling in advanced endocrine and oncology research. This guide translates recent breakthroughs—including the use of Danazol-induced puberty models—into actionable protocols, troubleshooting insights, and workflow optimizations for translational scientists.

• D-Luciferin Potassium Salt: Powering Bioluminescence Imaging

  2026-05-11

  D-Luciferin (potassium salt) accelerates in vivo and in vitro assays with unmatched water solubility and purity, delivering sensitive, real-time bioluminescence imaging for tumor, stem cell, and reporter studies. Discover advanced protocols, troubleshooting strategies, and translational insights that distinguish APExBIO's reagent for high-impact research.

• LMO2-LDB1 Complex Drives AML Progression: Mechanistic Insigh

  2026-05-11

  This study elucidates how the interaction between LMO2 and transcription co-regulator LDB1 promotes acute myeloid leukemia (AML) cell proliferation and survival. Using integrative molecular and cellular approaches, the authors identify the LMO2/LDB1 complex as a critical oncogenic driver and potential therapeutic target in AML.

• One-step TUNEL FITC Apoptosis Detection Kit: Advanced Workfl

  2026-05-10

  Unlock sensitive, reproducible apoptosis detection in both tissue sections and cultured cells with the One-step TUNEL FITC Apoptosis Detection Kit. This article delivers protocol enhancements, troubleshooting strategies, and insights from cutting-edge research—empowering cancer and immunology investigators to achieve robust, high-impact DNA fragmentation assays.

• ATM Kinase Inhibition and Metabolic Targeting in HGSOC Cells

  2026-05-09

  This study reveals that ATM kinase activity is elevated in high grade serous ovarian cancer (HGSOC) and that its inhibition synergizes with the PPARα agonist fenofibrate to induce senescence in cancer cells. These findings highlight a promising metabolic combinatorial strategy for HGSOC cases resistant to standard DNA repair-targeted therapies.

• Distinct Apoptotic Pathways in BMECs Induced by Candida krus

  2026-05-08

  This study by Miao et al. provides the first detailed mechanistic comparison of how yeast and hypha phases of Candida krusei trigger apoptosis in bovine mammary epithelial cells (BMECs) through distinct signaling routes. These insights have direct implications for understanding fungal mastitis pathogenesis and identifying phase-specific molecular targets for apoptosis inhibition.

• Translating Dual-Fluorescence mRNA into Next-Gen Delivery In

  2026-05-08

  This thought-leadership article explores how EZ Cap™ Cy5 EGFP mRNA (5-moUTP) advances the field of mRNA delivery and translation efficiency assays, drawing on mechanistic insights, peer-reviewed breakthroughs, and real-world translational guidance for researchers. It contextualizes recent innovations in immunoevasive chemistry and dual-labeling, situating APExBIO’s reagent as a pivotal tool for quantitatively optimizing gene function studies and nanoparticle development.

• EphA2 as a Synthetic Lethal Target in MYC-Driven TNBC

  2026-05-07

  This study introduces a chemogenetic screen that identifies EphA2 inhibition as a synthetic lethal vulnerability in MYC-driven triple-negative breast cancer (TNBC). The findings establish EphA2 as a promising therapeutic target and detail a robust screening platform, providing new research directions for MYC-driven malignancies.

• Bradykinin B2 Receptors Regulate Ileal Peristalsis in Guinea

  2026-05-07

  This study delivers the first direct evidence that bradykinin inhibits the peristaltic reflex in the guinea pig ileum via B2 receptor activation. The findings clarify the receptor-specific regulation of intestinal motility and have implications for the selection and interpretation of ACE inhibitor models in hypertension and gastrointestinal research.

• Disulfiram: Synthetic Lethality and Proteasome Inhibition in

  2026-05-06

  Explore how Disulfiram, a dopamine β-hydroxylase inhibitor, enables synthetic lethality strategies in APC-deficient cancer models through proteasome inhibition and ROS pathway activation. This article delivers mechanistic insights and practical assay guidance for advanced cancer research.

• NU6300 Inhibits Gasdermin D-Mediated Pyroptosis via Cysteine

  2026-05-06

  The reference study identifies NU6300 as a covalent inhibitor of gasdermin D (GSDMD), targeting cysteine-191 to block GSDMD cleavage and palmitoylation, thereby suppressing pyroptotic cell death. These findings advance the understanding of inflammasome signaling modulation and provide a new chemical probe for dissecting pyroptosis and inflammation-related pathologies.

16226 records 1/1082 page Next 12345 下5页 Last page